Antiseizure Drug DIACOMIT Now Approved for Children as Young as 6 Months

SAN MATEO, Calif., Sept. 21, 2022 /PRNewswire/ -- Biocodex, Inc., a pharmaceutical company and manufacturer of DIACOMIT® (stiripentol), announced today that the U.S. Food and Drug Administration (FDA) has approved DIACOMIT for the treatment of seizures associated with Dravet syndrome in...

Click to view original post